# Efficacy and Safety of Peropirone Hydrochloride Tablets in the Treatment of Adolescent Bipolar Disorder Depression

> **NCT04826510** · PHASE4 · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 189 (estimated)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** Perospirone hydrochloride tablets
- **DRUG:** Lithium carbonate + perospirone hydrochloride
- **DRUG:** Lithium Carbonate Pill

## Key facts

- **NCT ID:** NCT04826510
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-25
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 189 (ESTIMATED)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04826510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04826510, "Efficacy and Safety of Peropirone Hydrochloride Tablets in the Treatment of Adolescent Bipolar Disorder Depression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04826510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*